FMO5
Basic information
Region (hg38): 1:147175351-147243050
Links
Phenotypes
GenCC
Source:
- congenital heart disease (Disputed Evidence), mode of inheritance: AD
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (87 variants)
- not_provided (4 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the FMO5 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000001461.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 83 | 87 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
Total | 0 | 0 | 83 | 5 | 1 |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
FMO5 | protein_coding | protein_coding | ENST00000254090 | 8 | 67771 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
3.70e-15 | 0.0113 | 125553 | 0 | 195 | 125748 | 0.000776 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.633 | 319 | 289 | 1.10 | 0.0000141 | 3525 |
Missense in Polyphen | 124 | 124.02 | 0.99981 | 1467 | ||
Synonymous | 0.727 | 90 | 99.2 | 0.907 | 0.00000472 | 1014 |
Loss of Function | -0.0623 | 22 | 21.7 | 1.01 | 0.00000111 | 271 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00292 | 0.00291 |
Ashkenazi Jewish | 0.000397 | 0.000397 |
East Asian | 0.000489 | 0.000435 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000628 | 0.000607 |
Middle Eastern | 0.000489 | 0.000435 |
South Asian | 0.00115 | 0.00108 |
Other | 0.00181 | 0.00179 |
dbNSFP
Source:
- Function
- FUNCTION: In contrast with other forms of FMO it does not seem to be a drug-metabolizing enzyme.;
- Pathway
- Drug metabolism - cytochrome P450 - Homo sapiens (human);Busulfan Pathway, Pharmacodynamics;Catalytic cycle of mammalian Flavin-containing MonoOxygenases (FMOs);Metapathway biotransformation Phase I and II;Selenoamino acid metabolism;nicotine degradation IV
(Consensus)
Recessive Scores
- pRec
- 0.0903
Intolerance Scores
- loftool
- 0.978
- rvis_EVS
- 0.07
- rvis_percentile_EVS
- 58.96
Haploinsufficiency Scores
- pHI
- 0.0441
- hipred
- N
- hipred_score
- 0.219
- ghis
- 0.387
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0707
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Fmo5
- Phenotype
- adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; cellular phenotype; homeostasis/metabolism phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);
Gene ontology
- Biological process
- biological_process;oxidation-reduction process
- Cellular component
- endoplasmic reticulum;endoplasmic reticulum membrane;cytosol;integral component of membrane;organelle membrane
- Molecular function
- monooxygenase activity;N,N-dimethylaniline monooxygenase activity;flavin adenine dinucleotide binding;NADP binding